Carlo Capalbo

2.7k total citations
54 papers, 1.4k citations indexed

About

Carlo Capalbo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Carlo Capalbo has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 20 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Carlo Capalbo's work include BRCA gene mutations in cancer (11 papers), Cancer Genomics and Diagnostics (9 papers) and HER2/EGFR in Cancer Research (5 papers). Carlo Capalbo is often cited by papers focused on BRCA gene mutations in cancer (11 papers), Cancer Genomics and Diagnostics (9 papers) and HER2/EGFR in Cancer Research (5 papers). Carlo Capalbo collaborates with scholars based in Italy, United Kingdom and Sweden. Carlo Capalbo's co-authors include Giuseppe Giannini, Anna Coppa, Sonia D'inzeo, Arianna Nicolussi, Isabella Screpanti, Alessandra Tessitore, Francesca Zazzeroni, Edoardo Alesse, Alberto Gulino and Paolo Marchetti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Carlo Capalbo

51 papers receiving 1.4k citations

Peers

Countries citing papers authored by Carlo Capalbo

Since Specialization

Citations

This map shows the geographic impact of Carlo Capalbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Capalbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Capalbo more than expected).

Fields of papers citing papers by Carlo Capalbo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Capalbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Capalbo. The network helps show where Carlo Capalbo may publish in the future.

Co-authorship network of co-authors of Carlo Capalbo

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Capalbo. A scholar is included among the top collaborators of Carlo Capalbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Capalbo. Carlo Capalbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Thymic-Epithelial-Cell-Dependent Microenvironment Influences Proliferation and Apoptosis of Leukemic Cells 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Carlo Capalbo, Franco Locatelli, Alberto Macone, Enrico Velardi, Rocco Palermo, María Pía Felli	0
2	Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients 2024 ·Journal of Translational Medicine ·Marianna Talia, (unknown), Francesca Cirillo, (unknown), (unknown), (unknown), (unknown), Maria Antonietta Occhiuzzi, Ernestina Marianna De Francesco, Antonino Belfiore, Anna Miglietta, Michele Di Dio, Carlo Capalbo, Marcello Maggiolini, Rosamaria Lappano	8
3	Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond 2024 ·Cancers ·Virginia Valentini, (unknown), (unknown), (unknown), (unknown), Carlo Capalbo, Valentina Silvestri, Laura Ottini	12
4	Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach 2022 ·Radiology and Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Annalisa Milano, Michela Roberto, Carlo Capalbo, Federica Mazzuca	14
5	Nonthyroidal Illness Syndrome: To Treat or Not to Treat? Have We Answered the Question? A Review of Metanalyses 2022 ·Frontiers in Endocrinology ·Salvatore Sciacchitano, Carlo Capalbo, Christian Napoli, Paolo Anibaldi, (unknown), Claudia De Vitis, Rita Mancini, Flaminia Coluzzi, Monica Rocco	29
6	CT based radiomic approach on first line pembrolizumab in lung cancer 2021 ·Scientific Reports ·Marta Zerunian, Damiano Caruso, Alberto Zucchelli, Michela Polici, Carlo Capalbo, Marco Filetti, Federica Mazzuca, Paolo Marchetti, Andrea Laghi	28
7	Beyond BRCA1 and BRCA2: Deleterious Variants in DNA Repair Pathway Genes in Italian Families with Breast/Ovarian and Pancreatic Cancers 2020 ·Journal of Clinical Medicine ·Aldo Germani, Simona Petrucci, Laura De Marchis, (unknown), (unknown), C. Amanti, Adriana Bonifacino, (unknown), Carlo Capalbo, (unknown), (unknown), Mauro Mattei, Mattia Falchetto Osti, Patrizia Pellegrini, (unknown), (unknown), (unknown), Antonio Pizzuti, Maria Rosaria Torrisi, Maria Piane	7
8	Kras/ADAM17-Dependent Jag1-ICD Reverse Signaling Sustains Colorectal Cancer Progression and Chemoresistance 2019 ·Cancer Research ·Maria Pelullo, (unknown), (unknown), (unknown), Carmine Nicoletti, Zein Mersini Besharat, María Pía Felli, Bruna Cerbelli, Giulia d’Amati, Rocco Palermo, Carlo Capalbo, Claudio Talora, Lucia Di Marcotullio, Giuseppe Giannini, Saula Checquolo, Isabella Screpanti, Diana Bellavia	27
9	Diagnostic delay does not influence survival of pancreatic cancer patients 2019 ·United European Gastroenterology Journal ·(unknown), Lívia Archibugi, Serena Stigliano, Giuseppe Vanella, (unknown), Carlo Capalbo, Giuseppe Nigri, Gabriele Capurso	17
10	Identification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data 2019 ·PeerJ ·Arianna Nicolussi, Francesca Belardinilli, Valentina Silvestri, (unknown), Virginia Valentini, Sonia D'inzeo, Marialaura Petroni, Massimo Zani, S Ferraro, Stefano Di Giulio, Francesca Fabretti, (unknown), Angela Gradilone, Laura Ottini, Giuseppe Giannini, Anna Coppa, Carlo Capalbo	0
11	Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer 2019 ·PeerJ ·Arianna Nicolussi, Francesca Belardinilli, (unknown), Valeria Colicchia, Sonia D'inzeo, Marialaura Petroni, Massimo Zani, S Ferraro, Virginia Valentini, Laura Ottini, Giuseppe Giannini, Carlo Capalbo, Anna Coppa	14
12	Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 2017 ·Oncogene ·Agnese Pò, Marianna Silvano, Evelina Miele, Carlo Capalbo, Adriana Eramo, Valentina Salvati, Matilde Todaro, Zein Mersini Besharat, Giuseppina Catanzaro, Danilo Cucchi, Sonia Coni, Lucia Di Marcotullio, Gianluca Canettieri, Alessandra Vacca, Giorgio Stassi, Enrico De Smaele, Marco Tartaglia, Isabella Screpanti, Ruggero De Maria, Elisabetta Ferretti	87
13	PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma 2017 ·Oncogene ·Valeria Colicchia, Marialaura Petroni, Giulia Guarguaglini, (unknown), (unknown), Maurizio Carbonari, Biancamaria Ricci, (unknown), Carlo Capalbo, Francesca Belardinilli, Anna Coppa, Giovanna Peruzzi, Isabella Screpanti, Patrizia Lavia, Alberto Gulino, Giuseppe Giannini	66
14	Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer 2015 ·Clinical Biochemistry ·Francesca Belardinilli, Carlo Capalbo, (unknown), Marialaura Petroni, Valeria Colicchia, S Ferraro, Massimo Zani, Arianna Nicolussi, Sonia D'inzeo, Anna Coppa, Isabella Screpanti, Alberto Gulino, Giuseppe Giannini	20
15	Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors 2014 ·Cell Death and Disease ·Veronica Veschi, Marialaura Petroni, Armando Bartolazzi, (unknown), C Dominici, Carlo Capalbo, Renata Boldrini, Aurora Castellano, Heather P. McDowell, Barry Pizer, Luigi Frati, Isabella Screpanti, Alberto Gulino, Giuseppe Giannini	20
16	High-throughput microRNA profiling of pediatric high-grade gliomas 2013 ·Neuro-Oncology ·Evelina Miele, Francesca Romana Buttarelli, Antonietta Arcella, Federica Begalli, Neha Garg, Marianna Silvano, Agnese Pò, (unknown), (unknown), Manila Antonelli, Gian Paolo Spinelli, Carlo Capalbo, Vittoria Donofrio, Isabella Morra, Paolo Nozza, Alberto Gulino, Felice Giangaspero, Elisabetta Ferretti	28
17	PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms 2013 ·International Journal of Oncology ·Arianna Nicolussi, Sonia D'inzeo, Gabriella Mincione, (unknown), Maria Carmela Di Marcantonio, Roberto Cotellese, (unknown), Carlo Capalbo, Cira Di Gioia, Francesco Nardi, Giuseppe Giannini, Anna Coppa	27
18	HER2-positive male breast cancer: an update 2010 ·Breast Cancer Targets and Therapy ·Laura Ottini, Carlo Capalbo, Piera Rizzolo, Valentina Silvestri, (unknown), (unknown)	23
19	BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models 2006 ·Annals of Oncology ·Carlo Capalbo, Enrico Ricevuto, Annarita Vestri, (unknown), (unknown), (unknown), Bárbara Adamo, Enrico Cortesi, Paolo Marchetti, Giovanni Scambia, Federica Tomao, C Rinaldi, Massimo Zani, S Ferraro, L. Frati, Isabella Screpanti, Alberto Gulino, Giuseppe Giannini	27
20	Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software 2005 ·European Journal of Human Genetics ·Carlo Capalbo, Enrico Ricevuto, Annarita Vestri, (unknown), (unknown), Enrico Cortesi, Paolo Marchetti, Giovanni Scambia, Federica Tomao, C Rinaldi, Massimo Zani, S Ferraro, Luigi Frati, Isabella Screpanti, Alberto Gulino, Giuseppe Giannini	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact